Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;19(4):242-255.
doi: 10.2174/0115748871305325240511122602.

The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies

Nasim Rahimi-Dehkordi  1 , Saeid Heidari-Soureshjani  2 , Catherine M T Sherwin  3
Affiliations

The Effects and Safety of Silymarin on β-thalassemia in Children and Adolescents: A Systematic Review based on Clinical Trial Studies

Nasim Rahimi-Dehkordi et al. Rev Recent Clin Trials. 2024.

Abstract

Background: β-thalassemia imposes significant complications on affected patients. Silymarin, a natural flavonoid complex, has potential therapeutic properties.

Objective: This systematic review aims to comprehensively evaluate the literature on the mechanistic effects of Silymarin on β-thalassemia outcomes in children and adolescents.

Methods: A systematic search of electronic databases, including MEDLINE/PubMed, Embase, Scopus, Cochrane Library, and Web of Science (WOS), was done to identify relevant clinical trials before January 2024. Various data were extracted, including study characteristics, outcomes measured (hematological parameters, oxidative stress markers, iron metabolism, and other outcomes), proposed mechanisms, and safety.

Results: By iron chelation effects, Silymarin can reduce reactive oxygen species (ROS) production, increase intracellular antioxidant enzyme glutathione (GSH), and insert antioxidant effects. It also attenuated inflammation through reduced tumor necrosis factor-alpha (TNF-α), transforming growth factor-β1 (TGF-β1), interferon-gamma (IFNγ), C-reactive protein (CRP), interleukin 6 (IL-6), IL-17, and IL-23 levels and increase in IL-4 and IL-10 levels. By reducing iron overload conditions, Silymarin indicates modulatory effects on immune abnormalities, inhibits red blood cell (RBC) hemolysis, increases RBC count, and minimizes the need for a transfusion. Moreover, it reduces myocardial and hepatic siderosis, improves liver function tests, and modifies abnormal enzymes, particularly for aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), total bilirubin, and total protein levels. Silymarin also reduces iron overload, increases antioxidant and anti-inflammatory capacity in cardiomyocytes, and reveals antioxidant effects.

Conclusion: Silymarin indicates promising effects on various aspects of children and adolescents with β-thalassemia and has no serious side effects on the investigated dosage.

Keywords: Silymarin; beta-thalassemia; iron chelation effects; iron overload; red blood cells.; β-thalassemia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Bajwa H.; Basit H.; Thalassemia. StatPearls 2023
    1. Kattamis A.; Forni G.L.; Aydinok Y.; Viprakasit V.; Changing patterns in the epidemiology of β-thalassemia. Eur J Haematol 2020,105(6),692-703 - DOI - PubMed
    1. Sanchez-Villalobos M.; Blanquer M.; Moraleda J.M.; Salido E.J.; Perez-Oliva A.B.; New insights into pathophysiology of β-thalassemia. Front Med 2022,9,880752 - DOI - PubMed
    1. Nienhuis A.W.; Nathan D.G.; Pathophysiology and clinical manifestations of the -thalassemias. Cold Spring Harb Perspect Med 2012,2(12),a011726 - DOI - PubMed
    1. Hossain M.J.; Islam M.W.; Munni U.R.; Gulshan R.; Mukta S.A.; Miah M.S.; Sultana S.; Karmakar M.; Ferdous J.; Islam M.A.; Health-related quality of life among thalassemia patients in Bangladesh using the SF-36 questionnaire. Sci Rep 2023,13(1),7734 - DOI - PubMed

Publication types

LinkOut - more resources